[Therapy of micturition disorders].
D001418:Baclofen / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D002217:Carbachol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011726:Pyridinium Compounds / Q000627:therapeutic use; D014521:Urethra / Q000503:physiopathology; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology
D001626:Bethanechol Compounds; D011726:Pyridinium Compounds; D010643:Phenoxybenzamine; D002217:Carbachol; D001418:Baclofen; D010646:Phentolamine
Therapie der Blasenentleerungsstörungen.